Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases

JS Loh, WQ Mak, LKS Tan, CX Ng, HH Chan… - … and Targeted Therapy, 2024 - nature.com
The human gastrointestinal tract is populated with a diverse microbial community. The vast
genetic and metabolic potential of the gut microbiome underpins its ubiquity in nearly every …

Juvenile‐onset Huntington disease pathophysiology and neurodevelopment: a review

HS Bakels, RAC Roos… - Movement …, 2022 - Wiley Online Library
Huntington disease is an autosomal dominant inherited brain disorder that typically
becomes manifest in adulthood. Juvenile‐onset Huntington disease refers to approximately …

Exome sequencing of individuals with Huntington's disease implicates FAN1 nuclease activity in slowing CAG expansion and disease onset

B McAllister, J Donaldson, CS Binda, S Powell… - Nature …, 2022 - nature.com
The age at onset of motor symptoms in Huntington's disease (HD) is driven by HTT CAG
repeat length but modified by other genes. In this study, we used exome sequencing of 683 …

Genetic modifiers of Huntington disease differentially influence motor and cognitive domains

JM Lee, Y Huang, M Orth, T Gillis, J Siciliano… - The American Journal of …, 2022 - cell.com
Genome-wide association studies (GWASs) of Huntington disease (HD) have identified six
DNA maintenance gene loci (among others) as modifiers and implicated a two step …

Gut microbiota dysbiosis and Huntington's disease: Exploring the gut-brain axis and novel microbiota-based interventions

G Sharma, SS Biswas, J Mishra, U Navik, R Kandimalla… - Life Sciences, 2023 - Elsevier
Huntington's disease (HD) is a complex progressive neurodegenerative disorder affected by
genetic, environmental, and metabolic factors contributing to its pathogenesis. Gut dysbiosis …

Dissecting the relationship between neuropsychiatric and neurodegenerative disorders

R Gupta, D Advani, D Yadav, RK Ambasta… - Molecular …, 2023 - Springer
Neurodegenerative diseases (NDDs) and neuropsychiatric disorders (NPDs) are two
common causes of death in elderly people, which includes progressive neuronal cell death …

Disordered decision making: a cognitive framework for apathy and impulsivity in huntington's disease

LA Morris, C O'Callaghan, C Le Heron - Movement Disorders, 2022 - Wiley Online Library
A caregiver's all‐too‐familiar narrative‐“He doesn't think through what he does, but mostly
he does nothing.” Apathy and impulsivity, debilitating and poorly understood, commonly co …

Mutant huntingtin confers cell-autonomous phenotypes on Huntington's disease iPSC-derived microglia

N Stöberl, J Donaldson, CS Binda, B McAllister… - Scientific Reports, 2023 - nature.com
Huntington's disease (HD) is a neurodegenerative disorder caused by a dominantly
inherited CAG repeat expansion in the huntingtin gene (HTT). Neuroinflammation and …

Improving mood and cognitive symptoms in Huntington's disease with cariprazine treatment

MJ Molnar, V Molnar, M Fedor, R Csehi, K Acsai… - Frontiers in …, 2022 - frontiersin.org
In Huntington's disease (HD), the main clinical symptoms include depression, apathy,
cognitive deficits, motor deficiencies and involuntary movements. Cognitive, mood and …

Brain-derived neurotrophic factor dysregulation as an essential pathological feature in Huntington's disease: mechanisms and potential therapeutics

A Speidell, N Bin Abid, H Yano - Biomedicines, 2023 - mdpi.com
Brain-derived neurotrophic factor (BDNF) is a major neurotrophin whose loss or interruption
is well established to have numerous intersections with the pathogenesis of progressive …